| 7291- | GGB, | Inhibition of P-glycoprotein leads to improved oral bioavailability of compound K, an anticancer metabolite of red ginseng extract produced by gut microflora |
| - | in-vivo, | Nor, | NA |
| 7294- | GGB, | Ginsenoside Rg3 inhibits angiogenesis in gastric precancerous lesions through downregulation of Glut1 and Glut4 |
| - | vitro+vivo, | GC, | NA |
| 7293- | GGB, | Ginsenoside Rh2 and Rg3 inhibit cell proliferation and induce apoptosis by increasing mitochondrial reactive oxygen species in human leukemia Jurkat cells |
| - | in-vitro, | AML, | NA |
| - | Review, | Var, | NA |
| 7286- | GGB, | Ginsenoside Rh2 shifts tumor metabolism from aerobic glycolysis to oxidative phosphorylation through regulating the HIF1-α/PDK4 axis in non-small cell lung cancer |
| - | in-vitro, | Lung, | A549 | - | in-vitro, | Lung, | PC9 |
| 7287- | GGB, | Rad, | Ginsenoside Rg3 enhances the radiosensitivity of lung cancer A549 and H1299 cells via the PI3K/AKT signaling pathway |
| - | in-vitro, | Lung, | NA |
| 7288- | GGB, | Anti-Angiogenic Properties of Ginsenoside Rg3 Epimers: In Vitro Assessment of Single and Combination Treatments |
| - | in-vitro, | BC, | MDA-MB-231 |
| 7217- | GGB, | Role of Ginkgolides in the Inflammatory Immune Response of Neurological Diseases: A Review of Current Literatures |
| - | Review, | AD, | NA |
| 7221- | GGB, | GEM, | Ginkgolide B enhances gemcitabine sensitivity in pancreatic cancer cell lines via inhibiting PAFR/NF-кB pathway |
| - | in-vitro, | PC, | NA |
| 7141- | GI, | Synthesis of New Shogaol Analogues as NRF2 Activators and Evaluation of Their Anti-Inflammatory Activity, Modes of Action and Metabolic Stability |
| - | Study, | Nor, | BV2 |
| 7142- | GI, | Phase II study of the Effects of Ginger Root Extract on Eicosanoids in Colon Mucosa in People at Normal Risk for Colorectal Cancer |
| - | Trial, | Nor, | NA |
| 7143- | GI, | Chemo, | Effect of a Standardized Ginger Root Powder Regimen on Chemotherapy-Induced Nausea and Vomiting: A Multicenter, Double-Blind, Placebo-Controlled Randomized Trial |
| - | Trial, | Var, | NA |
| - | Trial, | Var, | NA |
| - | Trial, | BC, | NA |
| 7137- | GI, | 6-Shogaol from dried ginger inhibits growth of prostate cancer cells both in vitro and in vivo through inhibition of STAT3 and NF-κB signaling |
| - | in-vitro, | Pca, | LNCaP | - | in-vitro, | Pca, | DU145 | - | in-vitro, | Pca, | PC3 | - | vitro+vivo, | Pca, | HMVP2 |
| 7136- | GI, | [6]-shogaol inhibits growth and induces apoptosis of non-small cell lung cancer cells by directly regulating Akt1/2 |
| - | vitro+vivo, | NSCLC, | H1650 |
| 7151- | GI, | A novel shogaol analog suppresses cancer cell invasion and inflammation, and displays cytoprotective effects through modulation of NF-κB and Nrf2-Keap1 signaling pathways |
| - | in-vitro, | BC, | MDA-MB-231 | - | in-vitro, | BC, | MCF7 | - | in-vitro, | Nor, | RAW264.7 |
| 7140- | GI, | Benefits of Ginger and Its Constituent 6-Shogaol in Inhibiting Inflammatory Processes |
| - | Review, | Var, | NA |
| 7139- | GI, | 6-Shogaol Exhibits a Promoting Effect with Tax via Binding HSP60 in Non-Small-Cell Lung Cancer |
| - | vitro+vivo, | Lung, | A549 | - | in-vitro, | Melanoma, | A375 | - | in-vitro, | GBM, | U251 |
| 7152- | GI, | Role of Ginger in management of nausea among patients receiving chemotherapy |
| - | Trial, | Var, | NA |
| 7135- | GI, | Examination of the Pharmacokinetics of Active Ingredients of Ginger in Humans |
| - | Trial, | Nor, | NA |
| 7154- | GI, | Chemo, | Effects of Ginger Intake on Chemotherapy-Induced Nausea and Vomiting: A Systematic Review of Randomized Clinical Trials |
| - | Review, | Var, | NA |
| 7155- | GI, | BSB, | Effect of Ginger and Chamomile on Nausea and Vomiting Caused by Chemotherapy in Iranian Women with Breast Cancer |
| - | Trial, | BC, | NA |
| 7156- | GI, | Ginger-derived nanoparticles protect against alcohol-induced liver damage |
| - | in-vivo, | Nor, | NA |
| 7157- | GI, | Efficacy of ginger for nausea and vomiting: a systematic review of randomized clinical trials |
| - | Review, | Nor, | NA |
| 7158- | GI, | Ginger-partitioned moxibustion in the prevention of nausea and vomiting induced by chemotherapy in lung cancer:a randomized controlled trial |
| - | Trial, | Lung, | NA |
| 7138- | GI, | 6-Shogaol exerts anti-proliferative and pro-apoptotic effects through the modulation of STAT3 and MAPKs signaling pathways |
| - | vitro+vivo, | BC, | MDA-MB-231 | - | in-vitro, | Pca, | DU145 | - | in-vitro, | Liver, | HepG2 | - | in-vitro, | Lung, | A549 |
| 6771- | GI, | A glimpse on influences of ginger and its derivatives as a feed additive in finfish farming: A mini-review |
| - | Review, | Nor, | NA |
| 4246- | GI, | Ginger oil-loaded transdermal adhesive patch treats post-traumatic stress disorder |
| - | in-vivo, | NA, | NA |
| 4247- | GI, | 6-Shogaol from Dried Ginger Protects against Intestinal Ischemia/Reperfusion by Inhibiting Cell Apoptosis via the BDNF/TrkB/PI3K/AKT Pathway |
| - | vitro+vivo, | NA, | NA |
| 2464- | GI, | The Effect of Ginger (Zingiber officinale) on Platelet Aggregation: A Systematic Literature Review |
| - | Review, | Nor, | NA |
| 2465- | GI, | Effect of daily ginger consumption on platelet aggregation |
| - | Trial, | Nor, | NA |
| 1005- | GI, | Ginger Constituent 6-Shogaol Inhibits Inflammation- and Angiogenesis-Related Cell Functions in Primary Human Endothelial Cells |
| - | vitro+vivo, | Nor, | HUVECs |
| 1116- | GI, | 6-Shogaol Inhibits the Cell Migration of Colon Cancer by Suppressing the EMT Process Through the IKKβ/NF-κB/Snail Pathway |
| - | in-vitro, | Colon, | Caco-2 | - | in-vitro, | CRC, | HCT116 |
| 7261- | Gink, | Ginkgetin induces apoptosis in 786-O cell line via suppression of JAK2-STAT3 pathway |
| - | in-vitro, | RCC, | 786-O |
| 7242- | Gink, | Cisplatin, | Ginkgetin reverses cisplatin resistance in cervical cancer by regulating the Nrf2/HO-1 signaling pathway to induce ferroptosis |
| - | in-vitro, | Cerv, | HeLa |
| - | vitro+vivo, | Lung, | A549 | - | in-vitro, | Lung, | H1299 |
| 7244- | Gink, | Ginkgetin Blocks Constitutive STAT3 Activation and Induces Apoptosis through Induction of SHP-1 and PTEN Tyrosine Phosphatases |
| - | in-vitro, | Lung, | A549 | - | in-vitro, | Laryn, | FaDu |
| 7245- | Gink, | Ginkgetin inhibits the growth of DU-145 prostate cancer cells through inhibition of signal transducer and activator of transcription 3 activity |
| - | vitro+vivo, | Pca, | DU145 | - | in-vitro, | CRC, | HCT116 | - | in-vitro, | Nor, | MCF10 |
| 7246- | Gink, | Biflavone Ginkgetin, a Novel Wnt Inhibitor, Suppresses the Growth of Medulloblastoma |
| - | in-vitro, | GC, | DAOY | - | in-vitro, | MB, | D283 |
| 7247- | Gink, | Ginkgetin inhibits growth of breast carcinoma via regulating MAPKs pathway |
| - | in-vitro, | BC, | MDA-MB-231 | - | in-vitro, | BC, | BT474 | - | vitro+vivo, | BC, | MCF7 |
| 7248- | Gink, | Studies on the cytotoxic mechanisms of ginkgetin in a human ovarian adenocarcinoma cell line |
| - | in-vitro, | Ovarian, | OVCAR-3 | - | in-vitro, | Cerv, | HeLa | - | NA, | NA, | OV1369 |
| 7249- | Gink, | RES, | Synergy of Ginkgetin and Resveratrol in Suppressing VEGF-Induced Angiogenesis: A Therapy in Treating Colorectal Cancer |
| - | vitro+vivo, | NA, | NA |
| 7250- | Gink, | Ginkgetin from Ginkgo biloba: mechanistic insights into anticancer efficacy |
| - | Review, | Var, | NA |
| 7251- | Gink, | Ginkgetin: A Promising Multitarget Agent for Diverse Diseases |
| - | Review, | Var, | NA |
| 7252- | Gink, | STEAP2-associated modulation of PI3K/AKT/mTOR signaling contributes to ginkgetin-induced apoptosis in bladder cancer cells |
| - | in-vitro, | Bladder, | 5637 | - | in-vitro, | CRC, | T24/HTB-9 | - | in-vitro, | Bladder, | J82 | - | in-vitro, | Nor, | SV-HUC-1 |
| - | in-vitro, | Lung, | A549 | - | in-vitro, | Lung, | H1299 |
| 7260- | Gink, | Ginkgetin: A natural biflavone with versatile pharmacological activities |
| - | Review, | Var, | NA | - | Review, | Stroke, | NA | - | Review, | AD, | NA |
| 7262- | Gink, | Ginkgetin suppresses ovarian cancer growth through inhibition of JAK2/STAT3 and MAPKs signaling pathways |
| - | in-vitro, | Ovarian, | A2780S | - | in-vitro, | Ovarian, | SKOV3 |
| 7263- | Gink, | Ginkgetin delays the progression of osteoarthritis by inhibiting the NF-κB and MAPK signaling pathways |
| - | in-vitro, | ostP, | SW1353 |
Query results interpretion may depend on "conditions" listed in the research papers. Such Conditions may include : -low or high Dose -format for product, such as nano of lipid formations -different cell line effects -synergies with other products -if effect was for normal or cancerous cells
Filter Conditions: Pro/AntiFlg:% IllCat:% CanType:% Cells:% prod#:% Target#:% State#:% Dir#:%
wNotes=0 sortOrder:rid,rpid